Know What's Happening in Healthcare
Know What's Happening in Healthcare
FDA approves KRESLADI, first CIRM‑backed gene‑editing therapy
The FDA cleared KRESLADI, a gene‑editing treatment from Rocket Pharmaceuticals for severe leukocyte adhesion deficiency‑I in children, eliminating the need for a bone‑marrow donor. It is the first product directly funded by California’s Institute for Regenerative Medicine to receive approval.
Also developing:
By the numbers: Syneron Bio raises $150M Series B
Palantir Technologies, the US data‑fusion and AI firm, has secured contracts with the UK National Health Service and the Ministry of Defence. Critics argue the deals give a surveillance‑focused company access to sensitive citizen data. The firm’s platforms, already employed for US immigration enforcement and Israeli military operations, raise concerns about opaque algorithms and democratic accountability. Letters to the Guardian call for a reassessment of the procurement process and stronger data‑rights protections.
Shannon Kennedy will present a HIMSS 2026 workshop that applies space‑medicine constraints to redesign value‑based care. She introduces the "Orbital Quintuple Aim" framework, which evaluates five interdependent dimensions of health delivery under extreme resource limits. Participants act as spacecraft medical...
The Trump administration is constructing a federal digital backbone to support the Great Healthcare Plan, focusing on interoperability, patient identity verification, and transparent prescription pricing. The Centers for Medicare and Medicaid Services are advancing a Health Technology Ecosystem that will...
SIIM is expanding its educational offerings to cultivate imaging informatics champions, providing training, mentorship, and a new virtual hospital sandbox for safe IT practice. The society’s partnership with RSNA has produced a National Imaging Informatics Course, creating a standardized pathway...
Measurement‑Based Care (MBC) uses patient‑reported outcome measures like PHQ‑9 and GAD‑7 to turn subjective symptoms into quantitative data, driving up to 95 % improvement in outcomes. As patient volumes grow, manual MBC processes become inefficient, leading to incomplete assessments, clinician burnout,...
Georgia faces a silent kidney disease crisis, with 1.2 million adults affected and only 147,000 aware of their condition. Dr. Sharica Brookins launched Remote Renal Care in 2018, the state’s first fully virtual nephrology practice, to bridge the specialist gap in...
CMS has released draft regulations that will reshape Medicare Advantage (MA) and Affordable Care Act (ACA) Marketplace operations beginning in the 2027 compliance year. The proposals tighten enrollment verification, mandate greater cost and benefit transparency, and introduce stricter documentation standards...
Generate Biomedicines, Inc. (GENB) launched a $400 million IPO on Feb 23, 2026, offering 25 million shares at $15‑$17 each on NASDAQ. At the midpoint price of $16, the company would be valued at roughly $2.04 billion. The proceeds are earmarked for two Phase 3 trials...
The FDA released draft guidance introducing the Plausible Mechanism Framework, a new approval pathway for individualized therapies targeting ultra‑rare diseases. The framework permits sponsors to seek clearance for gene‑editing and RNA‑based treatments when traditional randomized trials are infeasible due to...
Researchers unveiled Whole‑Slide Edge Tomography, an AI‑driven 3D scanning platform that digitizes every cell on a cytology slide and classifies abnormalities with near‑human accuracy. In tests on cervical samples, the system recorded AUC scores from 0.84 for early changes up...
The FDA’s Commissioner’s National Priority Review Voucher (CNPV) pilot compresses review timelines to one‑to‑two months for qualifying drugs, but its criteria favor applications with mature data packages. Compass Pathways’ synthetic psilocybin (COMP360) was listed as eligible yet did not receive...
Recent analyses of BCMA CAR‑T therapies reveal that superior response rates can be achieved without the historically accepted trade‑off of delayed movement and neurocognitive toxicities (MNTs). Emerging data pinpoint specific construct features—particularly signaling domains and hinge designs—as the primary drivers...
Balancing potency with oral bioavailability remains a core hurdle as drug candidates grow larger and more complex. Researchers now focus on "chameleonicity"—the ability of a molecule to toggle between polar and lipophilic conformations—to reconcile solubility and permeability. The article outlines...
Pixel Health unveiled One Thread™, an AI‑powered experience layer that sits above existing EMR and technology stacks to unify patient portals, apps, websites, and contact centers. The platform provides a universal patient identity, personalized interactions, and automated workflow coordination while...
Health systems are confronting fragmented behavioral‑health delivery through multiple tactics, including rapid expansion of telepsychiatry, creation of integrated pediatric health hubs, and the launch of dedicated behavioral‑health urgent‑care sites. In West Virginia, virtual visits now account for just over half...
Surgeon Paul Toomey describes how outdated phone and scheduling systems cripple surgical practice efficiency, leading to patient frustration and staff burnout. He identifies interruptions—missed calls, last‑minute cancellations, and lack of shared accountability—as the primary sources of wasted time. By redesigning...
IRB Barcelona has unveiled Spain’s first fully integrated spatial omics platform, uniting spatial transcriptomics, proteomics, histopathology, advanced microscopy and bioinformatics under one workflow. The facility draws on five core units to deliver an end‑to‑end pipeline from sample preparation through computational...
A Taiwanese retrospective cohort of 24,259 adults with type 2 diabetes and liver cirrhosis found that initiating sodium‑glucose cotransporter‑2 inhibitors (SGLT2is) markedly reduced the risk of end‑stage kidney disease, acute kidney injury, major adverse cardiovascular events, all‑cause mortality, and hepatic decompensation...
Researchers unveiled a TadA‑embedded adenine base editor (TeABE) that precisely corrects the pathogenic A‑T to G‑C mutation in the CHD3 gene of a mouse model of Snijders Blok‑Campeau syndrome. Delivered via a dual‑AAV viral system, the editor restored normal CHD3 protein...
Fresenius Medical Care has adopted PTC’s digital‑thread platform to create an intelligent product lifecycle that unifies design, quality and manufacturing data. The solution builds a shared product data foundation, enhancing traceability of requirements, design changes, and compliance documentation across cross‑functional...
Healthcare diagnostics firm Vikor Scientific, now operating as Vanta Diagnostics, disclosed a data breach affecting nearly 140,000 individuals. The breach was traced to Catalyst RCM, a revenue-cycle‑management vendor, whose compromised credentials allowed the Everest ransomware group to exfiltrate roughly 12 GB...
Biotronik received FDA clearance for its Solia CSP S pacing lead, a device engineered specifically for left bundle branch area pacing (LBBAP). The lead combines a stylet‑driven platform with a novel fixed‑helix screw, addressing procedural simplicity and electrical performance. Approval relied on...
Syncx announced a wave of platform enhancements and AI‑driven capabilities that will roll out from February 23 through March. The VMS interface has been refreshed and performance boosted up to 60 percent in critical workflows while preserving existing user processes. Felix, the...
Weill Cornell Medicine has launched the AI to Advance Medicine initiative, an enterprise‑wide program that centralizes artificial‑intelligence projects across clinical care, research and education. The effort includes a bimonthly Dean’s Lecture Series and a seed‑grant program to fund AI tools,...
Researchers at Penn State used cryogenic electron microscopy to uncover how adding specific salts and water to the conductive polymer PEDOT:PSS creates hair‑like nanofibers that dramatically improve both stretchability and electrical conductivity. The nanostructure, revealed at –180 °C, shows that lithium‑based...
RevSpring, a revenue‑cycle management platform backed by Frazier Healthcare, announced the acquisition of healthcare‑technology firm TrustCommerce. The deal was sourced from Waud Capital Partners, which acted as the seller. TrustCommerce brings a robust payment‑processing suite that complements RevSpring's existing billing...
As someone researching aging during a time when everyone is trying to extend lifespan (and not necessarily healthspan), I beg you to read this entire🧵. Unless something changes, this is your future reality. You may already be dealing with this if...
NEW: The entire process of finding Medicare coverage may be influenced by artificial intelligence in the not-too-distant future. CMS wants to use AI tools for its "Medicare Experience Modernization" project — and there are lots of question marks. https://t.co/uSLFlAxViJ https://t.co/2bP3HnEDBx
In this episode, Kevin Wenceslau, Director of Clinical Solutions at Employers Health, explains how their clinical team uses evidence‑based insight to shape pharmacy benefit strategies for employers. He highlights their proactive utilization management—building custom clinical edits, collaborating with PBMs, and...
Building off the Baby KJ success story: FDA unveils long-awaited guidance on new pathway for individualized therapies - https://t.co/Uetp1cGFq2
Generate estimated it would price its shares at $15 to $17 apiece, translating to a valuation ranging from $1.91 billion to $2.17 billion — not counting an underwriter's option: https://t.co/n9nJsbJuvm
The health‑care sector’s shift to value‑based care is outpacing clinicians’ preparation for system‑level responsibilities. While medical training excels at diagnosis and treatment, it often omits the operational, financial, and population‑health skills required for coordinated outcomes. This misalignment creates early‑career attrition...
Fostering relationships with disabled communities could invite meaningful feedback during the design of assistive technologies, which could spark innovations that serve diverse populations. Learn more in Science #Robotics: https://t.co/NmJ6c2KIS5 https://t.co/zlhagQkRbw
Why is $BCAX testing a ficera dose in phase 3 that it now says isn't optimal (and other uncomfortable questions)? Via @ApexOnco -> https://t.co/mLWKP6AAZ9 $JNJ $GMAB
Recent research reveals that several snake lineages have completely lost the hunger hormone ghrelin and its activating enzyme, yet maintain normal energy balance. Modern anti‑obesity drugs, such as GLP‑1 receptor agonists, achieve weight loss by amplifying satiety signals rather than...
SpotitEarly, led by CEO Shlomi Madar, has unveiled a diagnostic platform that pairs trained detection dogs with electronic sensors and artificial intelligence to analyze patients' breath for early signs of cancer. The system can identify lung, prostate, colorectal and breast...
Mental health wards at Wrexham Maelor Hospital have gone live with electronic Prescribing and Medicines Administration (ePMA), the first in Wales to also record discharge medicines in the Shared Medicines Record (SMR). The early‑adopter rollout, led by Betsi Cadwaladr University...
BVI announced the first successful U.S. implantations of its FDA‑approved FINEVISION HP hydrophobic trifocal intraocular lens. Five leading cataract and refractive surgeons performed the procedures across multiple surgical centers. The lens, cleared by the FDA in October 2025, incorporates BVI’s proprietary POD...
Health systems face margin pressure, rising patient cost responsibility, and payer complexity, prompting a shift in revenue cycle workforce design for 2026. Integrating AI-driven automation with a strategically aligned global workforce and robust governance can improve denial management, clean claim...
The European Commission has pledged €225 million through a pre‑commercial procurement model to accelerate the development of next‑generation influenza vaccines. Ten entities, including Sanofi and Bavarian Nordic, will receive eight‑year contracts that cover clinical testing through market authorisation. The funding targets...
That feeling you get when you run a head-to-head study and the rival drug beats you out. Spending a fortune to hand your competitor a marketing message. Sometimes it feels like $NOVO is snake bit. $LLY https://t.co/gGUjl6iqPg
The Centers for Disease Control and Prevention announced that Dr. Ralph Abraham has resigned as Principal Deputy Director, effective immediately, to address unforeseen family obligations. Abraham, who joined the role in 2024, was recognized for enhancing national preparedness and streamlining...
Health‑tech AI pilots are booming, yet MIT’s 2025 State of AI report finds 95% fail to generate value. High‑profile failures like Forward Health’s CarePods and Olive AI illustrate how operational complexity and unfocused expansion derail scaling. The article argues that...
The module outlines a five‑dimensional framework for target selection, linking biological relevance, drugability, disease impact, competitive landscape, and development risk. It contrasts first‑in‑class and best‑in‑class strategies, highlighting how pioneering mechanisms can command premium market positions. The content identifies oncology as...
Goal-Driven Flexible Bayesian Design presentation updated w/comparison of performance of frequentist group sequential designs: https://t.co/QCZ6DQrm07 . Frequentist approach takes far too long to make a decision by controlling something that is NOT an error prob. #Statistics #rct https://t.co/X2knbmzTuX
My @CNBC segment on how President Trump's drug pricing deals will achieve many of the initial aims set out by tariff proposals, with respect to reshoring drug manufacturing, and how the biggest consumer impact in terms of lower drug costs...
Ultima Genomics announced the UG 200 series, a second‑generation sequencing platform that includes a single‑wafer UG 200 and a dual‑wafer UG 200 Ultra. Both instruments are half the size of the UG 100, cost less (starting at $850,000), and deliver...
GH Research’s inhaled mebufotenin (GH001) demonstrated ultra‑rapid, profound antidepressant effects in a Phase 2b trial for treatment‑resistant depression, with 73% of patients in remission after six months versus ~11% for standard oral therapies. Early‑stage studies in postpartum depression and bipolar disorder...
Gilead Sciences agreed to acquire the remaining shares of Arcellx for an equity value of $7.8 billion, paying $115 per share—a 79.4% premium to the prior close. The deal secures full rights to Arcellx’s BCMA‑directed CAR‑T therapy anito‑cel, which is in...
Asda Opticians is committing £2.5 million to upgrade its optical estate, refit 18 stores and modernise diagnostic equipment. The investment also funds a new suite of technical, leadership and personal‑development training, plus a third Level 6 Dispensing Optician apprenticeship cohort beginning September 2026....
